华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03069 华夏恒生生科

交易中 08-25 15:06:12

16.150

+0.410

+2.60%

最高16.150	最低15.690	成交量1,483万
今开15.830	昨收15.740	日振幅2.92%
总市值26.27亿	流通市值26.27亿	总股本1.63亿
成交额2.36亿	换手率9.12%	流通股本1.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03069","market":"HK","secType":"STK","nameCN":"华夏恒生生科","latestPrice":16.15,"timestamp":1787641376239,"preClose":15.74,"halted":0,"volume":14826808,"delay":0,"changeRate":0.02604828462515873,"floatShares":162657666,"shares":162657666,"eps":0,"marketStatus":"交易中","change":0.41,"latestTime":"08-25 15:06:12","open":15.83,"high":16.15,"low":15.69,"amount":235829853,"amplitude":0.029225,"askPrice":16.16,"askSize":36500,"bidPrice":16.14,"bidSize":429100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787645400000},"marketStatusCode":2,"adr":0,"listingDate":1615996800000,"exchange":"SEHK","adjPreClose":15.74,"sharesOutstanding":237400000,"nav":15.7673,"aum":0,"dividendRate":0.003096,"bidAskSpread":0,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":1.011784,"lotSize":100,"spreadScale":3,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03069","defaultTab":"news","newsList":[{"id":"2661643312","title":"步长制药：注射用艾帕依泊汀α为公司子公司四川泸州步长生物制药有限公司自主研发的治疗用生物制品1类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2661643312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661643312?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:15","pubTimestamp":1787307315,"startTime":"0","endTime":"0","summary":"投资者提问：2026年07月28日药品通知件送达信息显示注射用艾帕依泊汀α未通过审批，请问公司创新药是自研还是合作模式？注射用艾帕依泊汀α为公司子公司四川泸州步长生物制药有限公司自主研发的治疗用生物制品1类新药。因该药品需进一步完善申报资料，经与国家药品审评中心沟通后，决定撤回注册申请，待完善相关资料后择期重新提交药品上市许可注册申请。截至目前该品种仍处于研发阶段，尚未纳入国家医保药品目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100033843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","03069","BK0239","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124447538","title":"港股生物科技股大涨，思路迪医药股份涨超80%，云顶新耀涨超60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124447538","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124447538?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:30","pubTimestamp":1787189405,"startTime":"0","endTime":"0","summary":"8月20日，港股$生物(000504)$科技股大涨，$思路迪医药股份(01244)$涨超80%，$云顶新耀(01952)$涨超60%，$康希诺生物(06185)$涨超50%，$艾美疫苗(06660)$涨超45%，$剂泰科技-P(07666)$涨超25%，$科济药业-B(02171)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03086","BK4588","BK1574","BK1587","BK1585","03455","06660","KCAI","09086","02834","01952","06185","BK1147","07522","TTTN","XLK","VXUS","07261","01244","07666","BK1191","03069","09834","VGT","07266","BK1515","03034","07568","02171","BK1583","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491288","title":"股市必读：中国医药（600056）8月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491288?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:55","pubTimestamp":1787079311,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，中国医药报收于9.44元，下跌0.63%，换手率0.88%，成交量13.22万手，成交额1.25亿元。董秘最新回复投资者： 要推动科技创新成果在卫生健康领域转化运用，推进全民健康数智化建设。请问公司在科技创新和健康数智化建设做了什么工作董秘： 您好！公司将结合自身业务实际，稳步推动科技创新成果转化与数智化转型升级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0082","BK0185","BK0028","03069","600056","BK0175","BK0010","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660463135","title":"中国医药：构建“小通智慧云药房”","url":"https://stock-news.laohu8.com/highlight/detail?id=2660463135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660463135?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:57","pubTimestamp":1787043439,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药08月18日在投资者关系平台上答复投资者关心的问题。请问公司在科技创新和健康数智化建设做了什么工作中国医药回复：您好！公司构建“小通智慧云药房”，提供云找药、互联网医院、健康管理等线上服务，同时扎实推进“数智穿透监管”与“AI+提效”两大工程。公司将结合自身业务实际，稳步推动科技创新成果转化与数智化转型升级。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800029033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0028","BK0010","BK0185","BK0082","BK0188","600056","03069","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431040","title":"股市必读：中国医药（600056）8月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660431040?lang=zh_cn&edition=full","pubTime":"2026-08-18 02:21","pubTimestamp":1786990869,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，中国医药报收于9.5元，下跌0.31%，换手率1.45%，成交量21.72万手，成交额2.05亿元。董秘最新回复投资者： 通用技术中国医药2026医药融合创新研讨会，请问公司邀请人来研讨，面对提问会回答吗？当日关注点交易信息汇总：8月17日主力资金净流出41.19万元，游资资金净流出1250.57万元，散户资金净流入1291.76万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800002311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0010","BK0188","BK0082","BK0185","BK0250","BK0028","03069","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659176884","title":"每周股票复盘：中国医药（600056）子公司获氨甲环酸片上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2659176884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659176884?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:33","pubTimestamp":1786818790,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，中国医药报收于9.53元，较上周的9.4元上涨1.38%。本周关注点来自公司公告汇总：子公司天方药业获批氨甲环酸片上市许可持有人变更。公司公告汇总中国医药全资子公司天方药业有限公司收到国家药监局核准签发的氨甲环酸片《药品补充申请批准通知书》，同意该药品上市许可持有人由浙江兄弟药业有限公司变更为天方药业有限公司。截至目前，国内已有包括天方药业在内的18家生产企业获得该药品批件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","03069","600056","BK0175","BK0185","BK0250","BK0010","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659296112","title":"智飞生物：专一专注专业深耕生物制药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2659296112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659296112?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:06","pubTimestamp":1786698388,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，近期生物制药领域各大公司股价都大幅上涨，贵公司股价却停滞不前，其原因是什么？该如何扭转当前局面？智飞生物回复：您好，二级市场股票价格受多种因素影响。公司专一、专注、专业地在生物制药领域深耕，持续开展产品创新，巩固核心竞争力；优化市场营销策略，提升商业推广效能；完善治理体系，强化全过程质量管理，为企业长远发展奠定坚实基础。公司的发展情况请您关注公司的信息披露，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400028168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","BK0077","BK0196","LU1328615791.USD","LU2148510915.USD","BK0188","LU2580892862.HKD","LU1064131003.USD","BK0046","300122","03069","BK0239","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659111226","title":"智飞生物：公司专一、专注、专业地在生物制药领域深耕","url":"https://stock-news.laohu8.com/highlight/detail?id=2659111226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659111226?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:06","pubTimestamp":1786698384,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，市场很多投资者因为选择投资智飞生物而后悔不已，这种消极的情绪和言传口碑，是否会直接或间接影响公司产品在全国各地的销售？针对这种连锁负反馈，公司是否制定相关措施来制止或弥补这一情况的发生？！请详细回答一下智飞生物回复：您好，二级市场股票价格受多种因素影响。公司专一、专注、专业地在生物制药领域深耕，为民众提供优质产品。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400028160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0077","LU2580892789.USD","LU1064130708.USD","BK0196","BK0239","LU1064131003.USD","300122","LU1328615791.USD","03069","LU2148510915.USD","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168288","title":"亚盛医药受邀出席Evercore第二届中国生物科技峰会并参加炉边谈话","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168288","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659168288?lang=zh_cn&edition=full","pubTime":"2026-08-13 21:13","pubTimestamp":1786626780,"startTime":"0","endTime":"0","summary":"中国苏州2026年8月13日 /美通社/ -- 致力于在肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药今日宣布，公司管理层将出席于2026年8月17日-19日在上海浦东丽思卡尔顿酒店举办的Evercore第二届中国生物科技峰会。会议期间，公司管理层将参与由Evercore研究团队主持的炉边谈话，并开展一对一投资者交流会。因此，该等前瞻性陈述不应被视为对未来事件的预测。无论出现新信息、未来事件或其他情况，亚盛医药均无义务更新或修订任何前瞻性陈述。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5025874_ZH25874_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5025874_ZH25874_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["KURE","EVR","AAPG","BK4127","BK4139","BK1161","06855","03069","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645670867","title":"ETF异动 | 华夏恒生生科(03069)涨超3% 机构指当前创新药板块估值吸引力提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2645670867","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645670867?lang=zh_cn&edition=full","pubTime":"2026-06-24 14:48","pubTimestamp":1782283723,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华夏恒生生科涨超3%。据悉，该ETF追踪恒生生物科技指数，其成份股涵盖康方生物、信达生物、百济神州等一批顶尖的、具备全球竞争力的中国生物科技企业。截至发稿，涨3.23%，报12.46港元，成交额1.22亿港元。兴业证券认为，近期多个创新药数据读出符合或略超市场预期，重要BD陆续公告，事件性催化不断，板块估值吸引力提升。长期看好具备差异化创新能力、全球BIC潜质及单品放量能力的创新药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4550","BK4588","06978","159992","BK1161","BK1574","BK4585","FDN","03069"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.1077},{"period":"3month","weight":0.1514},{"period":"6month","weight":-0.0038},{"period":"1year","weight":-0.0986},{"period":"ytd","weight":0.0969}],"compareEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0222},{"period":"3month","weight":-0.0032},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.007},{"period":"ytd","weight":-0.0044}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040155},{"month":2,"riseRate":0.4,"avgChangeRate":0.03003},{"month":3,"riseRate":0.2,"avgChangeRate":-0.029137},{"month":4,"riseRate":0.833333,"avgChangeRate":0.013346},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.016542},{"month":6,"riseRate":0.5,"avgChangeRate":0.022933},{"month":7,"riseRate":0.666667,"avgChangeRate":0.035744},{"month":8,"riseRate":0.5,"avgChangeRate":-0.010335},{"month":9,"riseRate":0.4,"avgChangeRate":0.026014},{"month":10,"riseRate":0.2,"avgChangeRate":-0.044379},{"month":11,"riseRate":0.6,"avgChangeRate":0.051035},{"month":12,"riseRate":0.2,"avgChangeRate":-0.056464}],"exchange":"SEHK","name":"华夏恒生生科","nameEN":"CAM HSBIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华夏恒生生科(03069)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华夏恒生生科,03069,华夏恒生生科股票,华夏恒生生科股票老虎,华夏恒生生科股票老虎国际,华夏恒生生科行情,华夏恒生生科股票行情,华夏恒生生科股价,华夏恒生生科股市,华夏恒生生科股票价格,华夏恒生生科股票交易,华夏恒生生科股票购买,华夏恒生生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华夏恒生生科(03069)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}